Latest News

Early notification of proposed admission to the Official List and cancellation of trading on AIM

30 July 2020

Tiziana Life Sciences plc the dual listed (NASDAQ:TLSA & UK AIMS:TILS) today announces its intention to apply for admission to listing of its ordinary shares (the "Ordinary Shares") on the standard listing segment of the Official List of the Financial...

Read more

Update on Timings and Corporate Actions

30 July 2020

New York/London, 30 July 2020 - Tiziana Life Sciences plc ("Tiziana", AIM: TILS, NASDAQ: TLSA) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, gives the following updates on corporate actions:

ADR Ratio...

Read more

Investor Webinar to Provide Corporate Updates and Q&A Session on July 30, 2020

30 July 2020

NEW YORK/LONDON, July 30, 2020 Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announced that Kunwar Shailubhai, Ph.D., the Company’s...

Read more

Exercise of Warrants and Issue of Equity and Total Voting Rights

24 July 2020

London, New York, 24 July 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and...

Read more

Director Appointment

20 July 2020

New York/London, 20 July 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, is...

Read more

Results of Annual General Meeting

16 July 2020

London, New York, 16 July 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the "Company" or "Tiziana"), a US and UK biotechnology company that focuses on the discovery and development of novel molecules to treat human disease...

Read more

Page 2 of 17 Previous Next